• Anaplastic Lymphoma Kinase (ALK) Gene Mutation Analysis
  • Partial Thromboplastin Time (PTT)
  • Complement Component C3A
  • Inhibin A and B, Tumor Marker
  • Squamous Cell Carcinoma Antigen (SSCA)
  • Polycythemia vera
  • Uric Acid, Body Fluid
  • Serotonin, 24 Hour, Urine
  • Rapid Plasma Reagin (RPR), CSF
  • MYH7 Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /NTRK Gene Fusion Panel (NTRK1, NTRK2, and NTRK3), Solid Tumors
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

NTRK Gene Fusion Panel (NTRK1, NTRK2, and NTRK3), Solid Tumors
Medical Test

Interpretation
Access to NTRK Gene Fusion Panel (NTRK1, NTRK2, and NTRK3), Solid Tumors is restricted.
Loading...